Terumo Corp. and Diabeloop are teaming up to develop an automated insulin delivery (AID) system for Japan and to offer more solutions to Europe, while also looking toward potential further global expansion. The plan is to develop a solution based on Diabeloop's DBLG1 and Terumo's MEDISAFE WITH, pictured above.
The DBLG1 algorithm-based system obtained CE marking in 2018, followed by the DBL-hu solution for highly unstable Type 1 diabetes management in 2020. The Diabeloop-developed self-learning algorithm is connected to a continuous glucose monitor (CGM) and an insulin pump. It analyzes data in real time and decides whether to maintain current insulin settings or adjust insulin delivery, the company reported in a news release.
In 2018, Terumo launched MEDISAFE WITH, an insulin patch pump that is designed to be wearable and lightweight. Terumo has also been the exclusive distributor of the Dexcom CGM system in Japan since 2019, according to the release.
"We always want to offer more choices to people living with diabetes. This new agreement will allow both companies to keep contributing to diabetes care with a real impact on clinical results while proposing safe and highly effective personalized solutions," stated Erik Huneker, founder and CEO of Diabeloop, in the release.
Added Yoshiya Kikawa, general manager, DM and Consumer Healthcare Group of Terumo: "We believe that this partnership will provide better treatment options for patients with diabetes around the world. Our vision is for our products and solutions to help patients manage their diabetes better and to make them feel unrestrained from diabetes."
"It is our great pleasure to enter into this comprehensive strategic partnership agreement. We have been providing cutting-edge solutions in the diabetes area since 1982. Together with Diabeloop, we are confident that we will be able to provide healthcare professionals and patients with value-added solutions not only in Japan but for all corners of the world," added Hikaru Samejima, President of Terumo's General Hospital Company.